Eve Health Group Limited has released a press release.
Placement to Chinese Pharmaceutical and Investment Group
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Earlier from EVE Health
- New Study- GlucoControl Improves Long-Term Glycaemic Control
- Omniblend Innovation Enters into US Representation Deal
- GlucoControl Momentum
- GlucoControl Pre-Meal Drink Launched
- Extension of Omniblend Innovation Tranche 2 Settlement
Later from EVE Health
- Omni Innovation secures UK Distribution Deal
- Omni Innovation Market Update
- Notification of Rights Issue Shortfall
- $1.6m Placement for Omni Innovation Investment
- Sales Results Exceed Expectations for Faulding GlucoControl
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health